Eaton Scientific Systems, Ltd. ("Eaton" or the "Company") a wholly-owned subsidiary of Pristine Solutions, Inc. (OTCQB: PRTN) is pleased to announce that the Company plans to begin development of a transdermal patch delivery system for Tropine 3, a patent pending novel indication of homatropine for non-hormonal treatment of hot flashes in pre-menopausal, peri-menopausal, and post-menopausal women. The Company believes that this will be the world's first ever available prescription non-hormonal transdermal treatment for hot flash symptoms.
About OTCtipReporter.com
OTCtipReporter.com Reports Wall Street’s Top Emerging Growth Companies in our free penny stock Newsletter daily. OTCtipReporter.com continues to put out the best penny stock alerts in today’s penny stock market. Our exceptional accuracy for big penny stock winners is apparent by our large membership. Our goal is to provide you with the latest insights in the market with stocks that can make you huge profits.
Sign up FREE for OTCtipReporter.com Daily Stock Alerts at: http://www.OTCtipReporter.com
We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by OTC Tip Reporter. Please be advised that the information provided May or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed.
